We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The approval “is an important advance for [asthma] patients as it allows them to benefit from triple therapy by using one inhaler once a day,” said GSK’s Chief Scientific Officer Hal Barron. Read More
The company plans to begin commercial sales of the products by the end of the year and is offering a free starter kit of composites to dentists. Read More
Nerivio’s smartphone app helps keep track of migraine episodes and offers analytics that can be shared with healthcare professionals to monitor and inform treatment. Read More
Undetected high levels of biotin in blood samples may cause false positive or negative results in certain clinical tests that are susceptible to biotin interference, the company said. Read More
The test “offers an alternative to lab-developed tests or analyte-specific reagent combinations, potentially minimizing variability and complexity in testing,” Roche said. Read More
The product is the first commercial test for fully automated high-throughput systems that can identify and differentiate between SARS-CoV-2, influenza A and influenza B using a single sample, according to the company. Read More